3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
33
Pain, Postoperative
4
Chronic Pain
3
Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Breast Diseases
2
Brain Neoplasms
2
Agnosia
2
Vulvodynia
1
Uterine Cervical Neoplasms
1
Skin Diseases
1
Seroma
1
Recurrence
1
Radiation Injuries
1
Postoperative Hemorrhage
1
Peripheral Nervous System Diseases
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, B-Cell, Marginal Zone
1
Hot Flashes
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Gangliosidosis, GM1
1
Gangliosidoses
1
Interventions
Fulvestrant
4
ribociclib
3
palbociclib
3
abemaciclib
3
Anastrozole
3
selpercatinib
2
exemestane
2
Trastuzumab
2
Letrozole
2
Gonadotropin-Releasing Hormone
2
Docetaxel
2
AZD9833
2
tucatinib
1
ipatasertib
1
glutathione pegylated liposomal doxorubicin
1
entinostat
1
elacestrant
1
atezolizumab
1
alectinib
1
Zoledronic Acid
1
Watchful Waiting
1
Trabectedin
1
Tamoxifen
1
Sodium Chloride
1
STX-478
1
RAD1901
1
Paclitaxel
1
Metformin
1
Imlunestrant
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms by Site
×
Sodium Chloride
×
Breast
×
Clear all
NCT01427400
2016-07-29
Botox
University of British Columbia
Phase 4
Unknown
128 enrolled